Uncontrolled Hypertension Increases with Age in an Older Community-Dwelling Chinese Population in Shanghai

Sheng Peng, Ting Shen, Jie Liu, Brian Tomlinson, Huimin Sun, Xiaoli Chen, Paul Chan, YaShu Kuang, Liang Zheng, Hong Wu, Xugang Ding, Dingguang Qian, Yixin Shen, Pingjin Gao, Huimin Fan, Zhongmin Liu, Yuzhen Zhang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We determined the prevalence of hypertension, medication usage and attainment of blood pressure goals in older (≥65 to <80 years and ≥80 years) urban community-dwelling Chinese subjects. Data were obtained in 3950 subjects (mean age 72.0 years, 1745 male) including 609 subjects aged ≥80 years in the Shanghai Elderly Cardiovascular Health Study (SHECHS). Established cardiovascular disease was present in 7.7% of participants. The prevalence of hypertension was 74.8% overall and it was more than 80% in individuals considered to be in moderate and higher cardiovascular disease risk categories. In hypertensive subjects, 67.1% were on treatment and treatment was more frequent in high and very high cardiovascular risk individuals. Attainment of the systolic blood pressure goal <150 mmHg was 62.9% and was greater in the ≥65 to <80 years group than in the ≥80 years group. The most commonly used antihypertensive treatments were calcium channel blockers (54.2%), followed by angiotensin receptor blockers (43.1%). Diuretics were used in 2.6%. Fixed-dose combination antihypertensive tablets were used in some of the ≥65 to <80 years group (12.4%) and more of the ≥80 years group (18.2%) and 70.9% of the ≥65 to <80 years group and 80.2% of the ≥80 years group were on monotherapy. There were high prevalence and high treatment rates of hypertension, but poor attainment of the systolic blood pressure goal of <150 mmHg, especially in the ≥80 years group of community-dwelling Chinese. Considering that more intensive treatment of hypertension in older subjects may be warranted after recent studies, this might be achieved by more frequent use of combinations of effective therapies and diuretics.

Original languageEnglish
Pages (from-to)558-569
Number of pages12
JournalAging and Disease
Volume8
Issue number5
DOIs
Publication statusPublished - Oct 2017

Fingerprint

Independent Living
Hypertension
Blood Pressure
Population
Diuretics
Antihypertensive Agents
Cardiovascular Diseases
Therapeutics
Angiotensin Receptor Antagonists
Calcium Channel Blockers
Tablets
Health

Keywords

  • Journal Article

Cite this

Uncontrolled Hypertension Increases with Age in an Older Community-Dwelling Chinese Population in Shanghai. / Peng, Sheng; Shen, Ting; Liu, Jie; Tomlinson, Brian; Sun, Huimin; Chen, Xiaoli; Chan, Paul; Kuang, YaShu; Zheng, Liang; Wu, Hong; Ding, Xugang; Qian, Dingguang; Shen, Yixin; Gao, Pingjin; Fan, Huimin; Liu, Zhongmin; Zhang, Yuzhen.

In: Aging and Disease, Vol. 8, No. 5, 10.2017, p. 558-569.

Research output: Contribution to journalArticle

Peng, S, Shen, T, Liu, J, Tomlinson, B, Sun, H, Chen, X, Chan, P, Kuang, Y, Zheng, L, Wu, H, Ding, X, Qian, D, Shen, Y, Gao, P, Fan, H, Liu, Z & Zhang, Y 2017, 'Uncontrolled Hypertension Increases with Age in an Older Community-Dwelling Chinese Population in Shanghai', Aging and Disease, vol. 8, no. 5, pp. 558-569. https://doi.org/10.14336/AD.2016.1220
Peng, Sheng ; Shen, Ting ; Liu, Jie ; Tomlinson, Brian ; Sun, Huimin ; Chen, Xiaoli ; Chan, Paul ; Kuang, YaShu ; Zheng, Liang ; Wu, Hong ; Ding, Xugang ; Qian, Dingguang ; Shen, Yixin ; Gao, Pingjin ; Fan, Huimin ; Liu, Zhongmin ; Zhang, Yuzhen. / Uncontrolled Hypertension Increases with Age in an Older Community-Dwelling Chinese Population in Shanghai. In: Aging and Disease. 2017 ; Vol. 8, No. 5. pp. 558-569.
@article{6e2de45d6cf349709664f97e7816f918,
title = "Uncontrolled Hypertension Increases with Age in an Older Community-Dwelling Chinese Population in Shanghai",
abstract = "We determined the prevalence of hypertension, medication usage and attainment of blood pressure goals in older (≥65 to <80 years and ≥80 years) urban community-dwelling Chinese subjects. Data were obtained in 3950 subjects (mean age 72.0 years, 1745 male) including 609 subjects aged ≥80 years in the Shanghai Elderly Cardiovascular Health Study (SHECHS). Established cardiovascular disease was present in 7.7{\%} of participants. The prevalence of hypertension was 74.8{\%} overall and it was more than 80{\%} in individuals considered to be in moderate and higher cardiovascular disease risk categories. In hypertensive subjects, 67.1{\%} were on treatment and treatment was more frequent in high and very high cardiovascular risk individuals. Attainment of the systolic blood pressure goal <150 mmHg was 62.9{\%} and was greater in the ≥65 to <80 years group than in the ≥80 years group. The most commonly used antihypertensive treatments were calcium channel blockers (54.2{\%}), followed by angiotensin receptor blockers (43.1{\%}). Diuretics were used in 2.6{\%}. Fixed-dose combination antihypertensive tablets were used in some of the ≥65 to <80 years group (12.4{\%}) and more of the ≥80 years group (18.2{\%}) and 70.9{\%} of the ≥65 to <80 years group and 80.2{\%} of the ≥80 years group were on monotherapy. There were high prevalence and high treatment rates of hypertension, but poor attainment of the systolic blood pressure goal of <150 mmHg, especially in the ≥80 years group of community-dwelling Chinese. Considering that more intensive treatment of hypertension in older subjects may be warranted after recent studies, this might be achieved by more frequent use of combinations of effective therapies and diuretics.",
keywords = "Journal Article",
author = "Sheng Peng and Ting Shen and Jie Liu and Brian Tomlinson and Huimin Sun and Xiaoli Chen and Paul Chan and YaShu Kuang and Liang Zheng and Hong Wu and Xugang Ding and Dingguang Qian and Yixin Shen and Pingjin Gao and Huimin Fan and Zhongmin Liu and Yuzhen Zhang",
year = "2017",
month = "10",
doi = "10.14336/AD.2016.1220",
language = "English",
volume = "8",
pages = "558--569",
journal = "Aging and Disease",
issn = "2152-5250",
publisher = "International Society on Aging and Disease",
number = "5",

}

TY - JOUR

T1 - Uncontrolled Hypertension Increases with Age in an Older Community-Dwelling Chinese Population in Shanghai

AU - Peng, Sheng

AU - Shen, Ting

AU - Liu, Jie

AU - Tomlinson, Brian

AU - Sun, Huimin

AU - Chen, Xiaoli

AU - Chan, Paul

AU - Kuang, YaShu

AU - Zheng, Liang

AU - Wu, Hong

AU - Ding, Xugang

AU - Qian, Dingguang

AU - Shen, Yixin

AU - Gao, Pingjin

AU - Fan, Huimin

AU - Liu, Zhongmin

AU - Zhang, Yuzhen

PY - 2017/10

Y1 - 2017/10

N2 - We determined the prevalence of hypertension, medication usage and attainment of blood pressure goals in older (≥65 to <80 years and ≥80 years) urban community-dwelling Chinese subjects. Data were obtained in 3950 subjects (mean age 72.0 years, 1745 male) including 609 subjects aged ≥80 years in the Shanghai Elderly Cardiovascular Health Study (SHECHS). Established cardiovascular disease was present in 7.7% of participants. The prevalence of hypertension was 74.8% overall and it was more than 80% in individuals considered to be in moderate and higher cardiovascular disease risk categories. In hypertensive subjects, 67.1% were on treatment and treatment was more frequent in high and very high cardiovascular risk individuals. Attainment of the systolic blood pressure goal <150 mmHg was 62.9% and was greater in the ≥65 to <80 years group than in the ≥80 years group. The most commonly used antihypertensive treatments were calcium channel blockers (54.2%), followed by angiotensin receptor blockers (43.1%). Diuretics were used in 2.6%. Fixed-dose combination antihypertensive tablets were used in some of the ≥65 to <80 years group (12.4%) and more of the ≥80 years group (18.2%) and 70.9% of the ≥65 to <80 years group and 80.2% of the ≥80 years group were on monotherapy. There were high prevalence and high treatment rates of hypertension, but poor attainment of the systolic blood pressure goal of <150 mmHg, especially in the ≥80 years group of community-dwelling Chinese. Considering that more intensive treatment of hypertension in older subjects may be warranted after recent studies, this might be achieved by more frequent use of combinations of effective therapies and diuretics.

AB - We determined the prevalence of hypertension, medication usage and attainment of blood pressure goals in older (≥65 to <80 years and ≥80 years) urban community-dwelling Chinese subjects. Data were obtained in 3950 subjects (mean age 72.0 years, 1745 male) including 609 subjects aged ≥80 years in the Shanghai Elderly Cardiovascular Health Study (SHECHS). Established cardiovascular disease was present in 7.7% of participants. The prevalence of hypertension was 74.8% overall and it was more than 80% in individuals considered to be in moderate and higher cardiovascular disease risk categories. In hypertensive subjects, 67.1% were on treatment and treatment was more frequent in high and very high cardiovascular risk individuals. Attainment of the systolic blood pressure goal <150 mmHg was 62.9% and was greater in the ≥65 to <80 years group than in the ≥80 years group. The most commonly used antihypertensive treatments were calcium channel blockers (54.2%), followed by angiotensin receptor blockers (43.1%). Diuretics were used in 2.6%. Fixed-dose combination antihypertensive tablets were used in some of the ≥65 to <80 years group (12.4%) and more of the ≥80 years group (18.2%) and 70.9% of the ≥65 to <80 years group and 80.2% of the ≥80 years group were on monotherapy. There were high prevalence and high treatment rates of hypertension, but poor attainment of the systolic blood pressure goal of <150 mmHg, especially in the ≥80 years group of community-dwelling Chinese. Considering that more intensive treatment of hypertension in older subjects may be warranted after recent studies, this might be achieved by more frequent use of combinations of effective therapies and diuretics.

KW - Journal Article

UR - http://www.scopus.com/inward/record.url?scp=85035103978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035103978&partnerID=8YFLogxK

U2 - 10.14336/AD.2016.1220

DO - 10.14336/AD.2016.1220

M3 - Article

C2 - 28966801

VL - 8

SP - 558

EP - 569

JO - Aging and Disease

JF - Aging and Disease

SN - 2152-5250

IS - 5

ER -